The invention is related to compounds of formula I
1
to pharmaceutical compositions comprising such compounds, to processes for the preparation of such compounds, and to methods of prevention and treatment of disorders, the progression of which involve an enhanced activity of matrix metalloproteinase 13, by administering to a patient in need thereof, a pharmaceutically effective amount of such compounds.
本发明涉及I1式化合物,以及包括此类化合物的药物组合物,制备此类化合物的过程,以及通过向需要此类化合物的患者施用药物有效量的方法,预防和治疗涉及基质
金属
蛋白酶13增强活性的疾病的进展。